Pfizer Stock Ratings for 2023 and Beyond
Pfizer Inc. (NYSE: PFE) helped the world overcome the worst of the COVID-19 pandemic by developing an innovative vaccine. How does Pfizer stock look now?
Posted by Money and Markets Staff | Jan 23, 2023 | Investing
Pfizer Inc. (NYSE: PFE) helped the world overcome the worst of the COVID-19 pandemic by developing an innovative vaccine. How does Pfizer stock look now?
Posted by Money and Markets Staff | Jan 23, 2023 | Investing
After energy crushed the market in 2022, you may be looking for more energy stocks to scoop up. What about Schlumberger stock?
Posted by Money and Markets Staff | Jan 23, 2023 | Investing
Shopify Inc. (NYSE: SHOP) has become the e-commerce platform of choice for many small business owners looking to sell online. But does that make Shopify stock a buy as online retail becomes the new norm?
Posted by Money and Markets Staff | Jan 22, 2023 | Investing
Electric vehicles (EVs) are the future, and many companies are capitalizing on this mega trend. Is Nio stock (Nasdaq: NIO) a buy in 2023?
Posted by Money and Markets Staff | Jan 21, 2023 | Investing
Eli Lilly and Co. (NYSE: LLY) is one of the world’s largest pharmaceutical companies. But does that mean Eli Lilly stock is one to buy today?
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below